Shares of Massachusetts-based biotech company Moderna were headed higher in Thursday’s trading session after the company reported third quarter revenue that skyrocketed. For the quarter, Moderna, who is one of the Covid-19 vaccine candidates closest to possible approval, reported a loss per share of 59 cents. Revenue however was $157.91 million, a staggering 826% growth. … Continue reading “Moderna Shares Explode as Company Collects Revenue on Covid Drug”
